References
- Birkedal-Hansen H, Moore WG, Bodden MK, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;4:197–250.
- Rutter JL, Mitchell TI, Buttice G, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 1998;58:5321–5.
- Rovin BH, Lu L, Saxena R. A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression. Biochem Biophys Res Commun 1999;259: 344–8.
- Rigby AS, Silman AJ, Gregory JC, et al. Investigating the HLA component in rheumatoid arthritis: an (additive) domi-nant role of inheritance is rejected, a recessive mode is preferred. Genet Epidemiol 1991;8:153–75.
- Wordsworth P, Pile KD, Buckley JD, et al. HLA hetero-zygosity contributes to susceptibility to rheumatoid arthritis. Am J Hum Genet 1992;51:585–91.
- Hasstedt SJ, Clegg DO, Ingles L, Ward RH. HLA-linked rheumatoid arthritis. Am J Hum Genet 1994;55:738–46.
- Arnett FC, Edworthy SM, Kaplan SR, et al. The American Rheumatism Association 1987 revised criteria for classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315–24.
- Hochberg MC, Chang RW, Dwosh I, et al. The American College of Rheumatology 1991 revised criteria for the classi-fication of global functional status in rheumatoid arthritis. Arthritis Rheum 1992;35:498–502.
- Roberts-Thomson PJ, McEvoy R, Langhans T, Bradley J. Routine quantification of rheumatoid factor by rale nephe-lometry. Ann Rheum Dis 1985;44:379–83.
- Murray GI, Duncan ME, Oneil P, et al. Matrix metalloproteinase-1 is associated with poor prognosis in colo-rectal cancer. Nat Med 1996;2:461–2.
- Murray GI, Duncan ME, Oneil P, et al. Matrix metalloproteinase-1 is associated with poor prognosis in esophageal cancer. J Pathol 1998;185:256–61.
- Vincenti MP, White LA, Schroen DJ, Benbow U, Brinckerhoff CE. Regulating expression of the gene for matrix metalloproteinase-1 (collagenase): mechanisms that control enzyme activity, transcription, and mRNA stability. Crit Rev Eukaryot Gene Expr 1996;6: 391–411.
- Maeda S, Sawai T, Uzuki M, et al. Determination of interstitial collagenase (MMP-1) in patients with rheumatoid arthritis. Ann Rheum Dis 1995;54:970–5.
- Rytter JL, Mitchell TI, Buttice G, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 1998;58:5321–5.
- Ellingsen T, Buus A, Stengaard-Pedersen K. Plasma monocyte chemoattractant protein 1 is a marker for joint inflammation in rheumatoid arthritis. J Rheumatol 2001;28: 41–6.
- Harigai M, Hara M, Yoshimura T, et al. Monocyte chemoattractant protein-1 in inflammatory joint diseases and its involvement in the cytokine network of rheumatoid synovium. Clin Immunol Immunopathol 1993;69:83–91.
- Zhu Y, Spitz MR, Mills GB, Wu X. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res 2001;61: 7825–9.
- Szalai C, Kozma GT, Nagy A, et al. Polymorphism in the gene regulatory region of MCP-1 is associated with asthma susceptibility and severity. J Allergy Clin Immunol 2001;108: 375–81.